Aethon

Mesa Royalties III Announces Mineral and Royalty Acquisition in the Haynesville Shale Play

Retrieved on: 
Wednesday, April 3, 2024
Professional Services, Mining, Minerals, Oil, Gas, Energy, Finance, Natural Resources, Permian, Weil, Gotshal & Manges, Acquisition, NGP, Aethon

Mesa Royalties III Holdings, LLC and affiliates (“Mesa”) is pleased to announce its acquisition of oil and gas mineral and royalty interests (“the Acquisition”) in the Haynesville shale play from an undisclosed private seller.

Key Points: 
  • Mesa Royalties III Holdings, LLC and affiliates (“Mesa”) is pleased to announce its acquisition of oil and gas mineral and royalty interests (“the Acquisition”) in the Haynesville shale play from an undisclosed private seller.
  • The Acquisition included approximately 6,200 net royalty acres across various counties and parishes in the core of the Haynesville shale play.
  • The Acquisition includes approximately 253 gross and 2.0 net producing wells operated by top operators Aethon, Southwestern, and Chesapeake.
  • Pro-forma following this acquisition Mesa will now own over 11,000 net royalty acres in the Haynesville shale play and plan to continue to aggregate to scale the position.”
    Weil, Gotshal & Manges LLP served as legal counsel for Mesa on the transaction.

Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs

Retrieved on: 
Thursday, April 4, 2024
Partner, EGFR, Oncogene, Partnership, RAS, Patient, Research, Aethon, Publication, Neoplasm, Therapy, BTK, Immune system, Apple tree, Pharmaceutical industry

NEW YORK, April 4, 2024 /PRNewswire/ -- Aethon Therapeutics, Inc., a biotechnology company discovering and developing novel antibody therapeutics designed to attack cancer cells in tandem with targeted covalent inhibitor cancer therapies, today announced that it has entered into a collaboration agreement with Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers. Under the terms of the agreement, Aethon will use its HapImmune™ platform to discover novel bispecific antibodies to mount an immune attack directed towards cancer cells hit by Revolution Medicines' RAS(ON) inhibitors, with the goal of fueling tumor clearance and helping to establish immune memory.

Key Points: 
  • The terms of the agreement provide for a multi-year collaboration under which Aethon is responsible for conducting preclinical work, with full reimbursement by Revolution Medicines.
  • Revolution Medicines has an option to conduct any clinical development of products that may arise from the collaboration.
  • The arrangement provides for both upfront and potential downstream payments covering future development and commercialization activities should Revolution Medicines exercise its option.
  • Beyond the programs being advanced in partnership with Revolution Medicines, Aethon has additional programs targeting validated covalent small molecules that inhibit RAS, EGFR, and BTK.

Black Stone Minerals, L.P. Announces Fourth Quarter and Full Year 2023 Results; Provides Guidance for 2024

Retrieved on: 
Tuesday, February 20, 2024
Energy, Natural Resources, Mining, Minerals, Oil, Gas, Permian, MMBTU, Mineral, Natural gas, Austin Chalk, Growth, Adjustment, BSM, Black Stone Minerals, Depression, Security (finance), Austin, Texas, JEA, Aethon

Black Stone Minerals, L.P. (NYSE: BSM) (“Black Stone Minerals,” “Black Stone,” or “the Company”) today announces its financial and operating results for the fourth quarter and full year of 2023 and provides guidance for 2024.

Key Points: 
  • Black Stone Minerals, L.P. (NYSE: BSM) (“Black Stone Minerals,” “Black Stone,” or “the Company”) today announces its financial and operating results for the fourth quarter and full year of 2023 and provides guidance for 2024.
  • Total reported production averaged 41.1 MBoe/d (95% mineral and royalty, 73% natural gas) for the fourth quarter of 2023.
  • Black Stone reported oil and gas revenue of $132.6 million (60% oil and condensate) for the fourth quarter of 2023, a decrease of 1% from $134.5 million in the third quarter of 2023.
  • Following are the key assumptions in Black Stone Minerals’ 2024 guidance, as well as comparable results for 2023:

Aethon Books teams with VoyceMe to adapt Six Webcomics!

Retrieved on: 
Thursday, October 5, 2023
Entertainment, Communications, General Entertainment, Online, Books, Publishing, Diamond, Partnership, Monster, Human, Multiverse, Science Fiction & Fantasy Translation Awards, NYT, Autumn, Crave, Psychokinesis, Monster Rancher, Book, Science fiction, Apocalypse Series (Kanso), Aethon, Element, Defiance, Amazon, Earth

Aethon Books is thrilled to announce our partnership with VoyceMe to adapt six of our series into webcomics, with plans to begin releasing episodes in 2024.

Key Points: 
  • Aethon Books is thrilled to announce our partnership with VoyceMe to adapt six of our series into webcomics, with plans to begin releasing episodes in 2024.
  • VoyceMe is the first social creator platform for manga, webtoons, and webnovels.
  • They’re a fresh new player in the world of webcomics behind hits such as God Game and The Mad Gate.
  • Knights Apocalyptica, by Zach Skye – A Progression Fantasy series where the Earth met its end and monsters spilled out.

Aethon Books and Laurel Pursuit Announce Major Webcomic Adaptations & Partnership!

Retrieved on: 
Friday, September 29, 2023
Other Entertainment, Publishing, Communications, Online, General Entertainment, Mobile Entertainment, Books, Entertainment, Tapas, FaZe Clan, Partnership, Overtime (sports network), Aethon, Interior design

Leading independent publisher Aethon Books has joined forces with top rising webcomic studio Laurel Pursuit to create a premier slate of new webcomics.

Key Points: 
  • Leading independent publisher Aethon Books has joined forces with top rising webcomic studio Laurel Pursuit to create a premier slate of new webcomics.
  • In teaming up with Laurel Pursuit, they hope to provide more ways for fans to experience their favorite properties.
  • From producing quality content to treating creators fairly every step of the way, Laurel Pursuit simply gets it.
  • Building off incredible momentum with major clients (such as Overtime Sports and FaZe Clan) and webcomic distributors, Laurel Pursuit is excited to deliver standout projects with meaningful storylines and memorable characters.

Aethon Energy Announces Executive Leadership Team Hires and Promotion

Retrieved on: 
Thursday, August 24, 2023
Finance, Alternative Energy, Energy, Professional Services, Other Energy, Heart, Commercial, Senior, General counsel, A&D, Management, Aethon

Aethon Energy Operating LLC (“Aethon”) announced the appointment of Andrea Wescott Passman as Chief Operating Officer, Kang Chen as Chief Information Officer, and Kat Lyles as General Counsel.

Key Points: 
  • Aethon Energy Operating LLC (“Aethon”) announced the appointment of Andrea Wescott Passman as Chief Operating Officer, Kang Chen as Chief Information Officer, and Kat Lyles as General Counsel.
  • Preston Phillips, Senior Vice President, A&D and Commercial, has also been promoted to Chief Commercial Officer.
  • “We are thrilled to welcome Andrea, Kang and Kat to our team, and to elevate Preston in recognition of his significant contributions to Aethon over more than 20 years,” said Albert Huddleston, Chief Executive Officer and Partner at Aethon.
  • “Aethon is well-positioned to play a more significant role in accelerating the energy transition, and I am excited to partner with our growing leadership team in delivering our goal of net-zero natural gas from wellhead to electron.”

Robot As A Service Market to Hit $4.12 Billion By 2030: Grand View Research, Inc.

Retrieved on: 
Tuesday, July 18, 2023
Human, Aethon, IRobot, Software, RaaS, SME, USD, Investment, SAN, Growth, Transport, Robotics, KUKA, Safety, Automation, Mobile phone, Speciality chemicals, 3D printing, Computer data storage

The logistics end-use segment is anticipated to witness the fastest CAGR of over 15.0% from 2023 to 2030.

Key Points: 
  • The logistics end-use segment is anticipated to witness the fastest CAGR of over 15.0% from 2023 to 2030.
  • The major companies operating in the market include KUKA AG, Fanuc Corporation, iRobot Corporation, and Aethon.
  • Startups in the market have received significant investments, which has enabled them to develop more advanced and sophisticated robots.
  • Service providers develop and offer software solutions for robot control and operating systems.

Robot As A Service Market to Hit $4.12 Billion By 2030: Grand View Research, Inc.

Retrieved on: 
Tuesday, July 18, 2023
Human, Aethon, IRobot, Software, RaaS, SME, USD, Investment, SAN, Growth, Transport, Robotics, KUKA, Safety, Automation, Mobile phone, Speciality chemicals, 3D printing, Computer data storage

The logistics end-use segment is anticipated to witness the fastest CAGR of over 15.0% from 2023 to 2030.

Key Points: 
  • The logistics end-use segment is anticipated to witness the fastest CAGR of over 15.0% from 2023 to 2030.
  • The major companies operating in the market include KUKA AG, Fanuc Corporation, iRobot Corporation, and Aethon.
  • Startups in the market have received significant investments, which has enabled them to develop more advanced and sophisticated robots.
  • Service providers develop and offer software solutions for robot control and operating systems.

Global Hospital Logistics Robots Market Report 2023: Sector is Expected to Reach $5.6 Billion by 2030 at a CAGR of 21.2% - ResearchAndMarkets.com

Retrieved on: 
Friday, June 9, 2023
Hospitals, Health, Robotics, Technology, Health Technology, Learning, ABB, Telehealth, Natural language processing, Communication, Aethon, Teradyne, Internet of things, ML, Research, Pharmacy, USD, NLP, Row, Patient, Application, Machine learning, AGV, Fourth Industrial Revolution, Artificial intelligence, Speciality chemicals, Medical device

The "Hospital Logistics Robots Market by Type and Application - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hospital Logistics Robots Market by Type and Application - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global hospital logistics robots market size was valued at USD 971.25 million in 2021, and is predicted to reach USD 5637.85 million by 2030, with a CAGR of 21.2% during the forecast period, 2022 to 2030.
  • Demand for hospital logistics robots has increased across the globe, owing to rise in need for remote care, such as telemedicine and telehealth.
  • The region dominates the hospital logistics robots market and is potently expected to remain dominant throughout the forecast period.

Medical Robotics Market to Grow Significantly by 2029- Brandessence Market Research

Retrieved on: 
Tuesday, May 30, 2023
Titan, Mazor Robotics, Renishaw plc, Intellectual property, Hansen Medical, Surgeon, Medicine, Prevalence, Aethon, IRobot, McKesson Corporation, Feedback, Intuitive Surgical, OR, Ageing, Cancer, Quality of life, Fatality, Laparoscopy, Research, Negotiation, MEA, Government, Smith & Nephew, Stryker Corporation, Hospital, Traction, Acquisition, Patient, Investment, Others, Risk, Robotics, Machine learning, Porter's five forces analysis, Conditional sentence, Artificial intelligence, Cyberdyne, Medtech, Medical device, Health insurance, Vaccine, 3D printing, Video game

The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.

Key Points: 
  • The business intelligence report on Medical Robotics Market by Brandessence Market Research presents a detailed overall of the crucial aspects of this industry.
  • The Medical Robotics Market is anticipated to grow substantially over the forecast duration of 2022-2029.
  • Competitive Rivalry: The medical robotics market is characterized by intense competition among key players.
  • Market leaders invest significantly in research and development to advance their robotic systems, enhance capabilities, and expand their product portfolios.